Cargando…
The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection
Helicobacter pylori infects the gastric mucosa of a large number of humans. Although asymptomatic in the vast majority of cases, H pylori infection can lead to the development of peptic ulcers gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. Using a variety of mechanisms...
Autores principales: | Oster, Paul, Vaillant, Laurie, McMillan, Brynn, Velin, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168074/ https://www.ncbi.nlm.nih.gov/pubmed/35677057 http://dx.doi.org/10.3389/fimmu.2022.899161 |
Ejemplares similares
-
GM‐CSF is key in the efficacy of vaccine‐induced reduction of Helicobacter pylori infection
por: Vaillant, Laurie, et al.
Publicado: (2022) -
Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies
por: Oster, Paul, et al.
Publicado: (2022) -
Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection
Publicado: (2023) -
Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses
por: Deng, Ruiyi, et al.
Publicado: (2022) -
The Influence of Mucus Microstructure and Rheology in Helicobacter pylori Infection
por: Bansil, Rama, et al.
Publicado: (2013)